Literature DB >> 31712221

PTEN Nuclear Functions.

Jason Ho1, Edward S Cruise2, Ryan J O Dowling1,2, Vuk Stambolic1,2.   

Abstract

For years, clinical and basic researchers have been aware of the presence of PTEN in the nucleus in cell culture, animal models, and both healthy and diseased human tissues. Despite the early recognition of nuclear PTEN, the understanding of the mechanisms of its nuclear localization, function in the nucleus, and importance in biology and human disease has been lacking. Over the last decade, emerging concepts for the complex involvement of nuclear PTEN in a variety of processes, including genome maintenance and DNA repair, cell-cycle control, gene expression, and DNA replication, are illuminating what could prove to be the key path toward a full understanding of PTEN function in health and disease. Dysregulation of nuclear PTEN is now considered an important aspect of the etiology of many pathologic conditions, prompting reconsideration of the therapeutic approaches aimed at countering the consequences of PTEN deficiency. This new knowledge is fueling the development of innovative therapeutic modalities for a broad spectrum of human conditions, from cancer and metabolic diseases, to neurological disorders and autism.
Copyright © 2020 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31712221      PMCID: PMC7197421          DOI: 10.1101/cshperspect.a036079

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  70 in total

1.  Growth and gene expression profile analyses of endometrial cancer cells expressing exogenous PTEN.

Authors:  M Matsushima-Nishiu; M Unoki; K Ono; T Tsunoda; T Minaguchi; H Kuramoto; M Nishida; T Satoh; T Tanaka; Y Nakamura
Journal:  Cancer Res       Date:  2001-05-01       Impact factor: 12.701

2.  TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta.

Authors:  D M Li; H Sun
Journal:  Cancer Res       Date:  1997-06-01       Impact factor: 12.701

3.  The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate.

Authors:  T Maehama; J E Dixon
Journal:  J Biol Chem       Date:  1998-05-29       Impact factor: 5.157

Review 4.  PTEN: a tumour suppressor that functions as a phospholipid phosphatase.

Authors:  T Maehama; J E Dixon
Journal:  Trends Cell Biol       Date:  1999-04       Impact factor: 20.808

5.  Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA Repair.

Authors:  Jianhui Ma; Jorge A Benitez; Jie Li; Shunichiro Miki; Claudio Ponte de Albuquerque; Thais Galatro; Laura Orellana; Ciro Zanca; Rachel Reed; Antonia Boyer; Tomoyuki Koga; Nissi M Varki; Tim R Fenton; Suely Kazue Nagahashi Marie; Erik Lindahl; Timothy C Gahman; Andrew K Shiau; Huilin Zhou; John DeGroot; Erik P Sulman; Webster K Cavenee; Richard D Kolodner; Clark C Chen; Frank B Furnari
Journal:  Cancer Cell       Date:  2019-02-28       Impact factor: 31.743

6.  Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner.

Authors:  Min Sup Song; Arkaitz Carracedo; Leonardo Salmena; Su Jung Song; Ainara Egia; Marcos Malumbres; Pier Paolo Pandolfi
Journal:  Cell       Date:  2011-01-21       Impact factor: 41.582

Review 7.  Functions of the centromere and kinetochore in chromosome segregation.

Authors:  Frederick G Westhorpe; Aaron F Straight
Journal:  Curr Opin Cell Biol       Date:  2013-03-13       Impact factor: 8.382

8.  SUMO, PTEN and Tumor Suppression.

Authors:  Michael J Matunis; Catherine M Guzzo
Journal:  Pigment Cell Melanoma Res       Date:  2012-07-31       Impact factor: 4.693

9.  Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN.

Authors:  V Stambolic; A Suzuki; J L de la Pompa; G M Brothers; C Mirtsos; T Sasaki; J Ruland; J M Penninger; D P Siderovski; T W Mak
Journal:  Cell       Date:  1998-10-02       Impact factor: 41.582

10.  PTEN regulates glioblastoma oncogenesis through chromatin-associated complexes of DAXX and histone H3.3.

Authors:  Jorge A Benitez; Jianhui Ma; Matteo D'Antonio; Antonia Boyer; Maria Fernanda Camargo; Ciro Zanca; Stephen Kelly; Alireza Khodadadi-Jamayran; Nathan M Jameson; Michael Andersen; Hrvoje Miletic; Shahram Saberi; Kelly A Frazer; Webster K Cavenee; Frank B Furnari
Journal:  Nat Commun       Date:  2017-05-12       Impact factor: 14.919

View more
  10 in total

Review 1.  The biochemical and clinical implications of phosphatase and tensin homolog deleted on chromosome ten in different cancers.

Authors:  Qinyi Wang; Junmin Wang; Hongjiao Xiang; Peilun Ding; Tao Wu; Guang Ji
Journal:  Am J Cancer Res       Date:  2021-12-15       Impact factor: 6.166

2.  Mouse model and human patient data reveal critical roles for Pten and p53 in suppressing POLE mutant tumor development.

Authors:  Vivian S Park; Meijuan J S Sun; Wesley D Frey; Leonard G Williams; Karl P Hodel; Juliet D Strauss; Sydney J Wellens; James G Jackson; Zachary F Pursell
Journal:  NAR Cancer       Date:  2022-03-03

3.  Germline nuclear-predominant Pten murine model exhibits impaired social and perseverative behavior, microglial activation, and increased oxytocinergic activity.

Authors:  Nick Sarn; Stetson Thacker; Hyunpil Lee; Charis Eng
Journal:  Mol Autism       Date:  2021-06-04       Impact factor: 7.509

Review 4.  PTEN Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine?

Authors:  Nicola Fusco; Elham Sajjadi; Konstantinos Venetis; Gabriella Gaudioso; Gianluca Lopez; Chiara Corti; Elena Guerini Rocco; Carmen Criscitiello; Umberto Malapelle; Marco Invernizzi
Journal:  Genes (Basel)       Date:  2020-06-28       Impact factor: 4.096

Review 5.  Small in Size, but Large in Action: microRNAs as Potential Modulators of PTEN in Breast and Lung Cancers.

Authors:  Asal Jalal Abadi; Ali Zarrabi; Mohammad Hossein Gholami; Sepideh Mirzaei; Farid Hashemi; Amirhossein Zabolian; Maliheh Entezari; Kiavash Hushmandi; Milad Ashrafizadeh; Haroon Khan; Alan Prem Kumar
Journal:  Biomolecules       Date:  2021-02-18

6.  Fluctuations in AKT and PTEN Activity Are Linked by the E3 Ubiquitin Ligase cCBL.

Authors:  Manuel Olazábal-Morán; Miriam Sánchez-Ortega; Laura Martínez-Muñoz; Carmen Hernández; Manuel S Rodríguez; Mario Mellado; Ana C Carrera
Journal:  Cells       Date:  2021-10-20       Impact factor: 6.600

7.  The PI3K/AKT Pathway and PTEN Gene Are Involved in "Tree-Top Disease" of Lymantria dispar.

Authors:  Fengjiao Li; Long Liu; Xiao Yu; Christopher Rensing; Dun Wang
Journal:  Genes (Basel)       Date:  2022-01-27       Impact factor: 4.096

Review 8.  The Role of PTEN in Epithelial-Mesenchymal Transition.

Authors:  Olga Fedorova; Sergey Parfenyev; Alexandra Daks; Oleg Shuvalov; Nickolai A Barlev
Journal:  Cancers (Basel)       Date:  2022-08-03       Impact factor: 6.575

9.  Potential Roles of PTEN on Longevity in Two Closely Related Argopecten Scallops With Distinct Lifespans.

Authors:  Hanzhi Xu; Xia Lu; Chunde Wang; Junhao Ning; Min Chen; Yuan Wang; Ke Yuan
Journal:  Front Physiol       Date:  2022-07-12       Impact factor: 4.755

Review 10.  Tumor Suppressors in Chronic Lymphocytic Leukemia: From Lost Partners to Active Targets.

Authors:  Giacomo Andreani; Giovanna Carrà; Marcello Francesco Lingua; Beatrice Maffeo; Mara Brancaccio; Riccardo Taulli; Alessandro Morotti
Journal:  Cancers (Basel)       Date:  2020-03-09       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.